Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve standalone unaudited financial results for the quarter ended on 30th June, 2026.
Jenburkt Pharmaceuticals Ltd Press Release Jul 29 2026
Earlier from Jenburkt Pharmaceuticals
- Jenburkt Pharmaceuticals Ltd Press Release Jul 13 2026
- Jenburkt Pharmaceuticals Ltd Press Release Jun 18 2026
- Jenburkt Pharmaceuticals Ltd Press Release May 27 2026
- Jenburkt Pharmaceuticals Ltd Press Release May 06 2026
